Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
Clinical trial NCT05363670 · COMPLETED
Trial details
- NCT number
- NCT05363670
- Sponsor
- ARS Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-28
- Primary completion
- 2024-02-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.